Skip to main content
Equibles

FRANKLIN RESOURCES INC

Position in GMAB — Genmab A/S

CIK 38777 San Mateo, CA
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$33,044,294
+$1,032,216 QoQ
Shares Held
1,202,923
+0.8% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 292 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. GMAB ranks #48 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,771,839 $1,728,352,485
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,347,253 $1,662,680,977
3 ASND
Ascendis Pharma A/S
 1,862,503 $496,766,798
4 JAZZ
Jazz Pharmaceuticals plc
 2,040,250 $491,639,040
5 RVMD
Revolution Medicines, Inc.
 1,488,394 $278,746,426
6 INSM
INSMED Inc
 2,273,222 $242,370,927
7 LGND
Ligand Pharmaceuticals Inc
 752,044 $237,713,585
8 ARGX
Argenx SE
 224,930 $208,683,303

All Filings in GMAB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,044,294 1,202,923
2026-03-31 $32,012,078 1,193,145
2025-12-31 $944,019 30,650
2025-09-30 $961,197 31,340
2025-06-30 $622,980 30,154
2025-03-31 $611,071 31,209
2024-12-31 $644,798 30,896
2024-09-30 $625,663 25,663
2024-06-30 $680,192 27,067
2024-03-31 $916,741 30,650
2023-12-31 $966,374 30,351
2023-09-30 $19,666,797 557,607
2023-06-30 $24,540,661 645,637
2023-03-31 $20,170,861 534,186
2022-12-31 $18,704,921 441,362
2022-09-30 $308,415 9,599
2022-06-30 $317,524 9,773
2022-03-31 $232,672 6,431
2021-12-31 $271,025 6,851
2021-09-30 $259,402 5,936
2021-06-30 $226,402 5,545
2020-12-31 $207,812 5,111